CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Friday reported a loss of $826 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $2.11.
The results topped Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $2.60 per share.
The biotechnology company posted revenue of $678 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $659.5 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA
About the Author
Discover more from USA NEWS
Subscribe to get the latest posts sent to your email.
